knowledge -WSS

knowledge

author：explore 2025-10-01 20:15:13 - browse：916

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

entertainment

WSS

FDA's naming rule on biosimilars has undermined competition

Food as medicine: Medically tailored meals may get standardized

Patient advocates debate FDA's accelerated approval process

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Food as medicine: Medically tailored meals may get standardized

Novo: Oral version of Ozempic leads to 15% weight loss

knowledge

knowledge

focus

Trump demands the U.S. pay no more for drugs than other countries … again

There's no autism epidemic. It's an autism diagnosis epidemic

Anesthesiologist group: stop taking Ozempic before surgery

Can medical device makers keep up in the race to treat obesity?

The cancer drug shortage isn’t new — and neither are the solutions

FDA approves first new drug developed for postpartum depression

What does generative AI mean for health care? We asked experts

Steward Health Care has deal to sell doctor network to UnitedHealth

Heart attack and stroke risk calculators need revising

The thinking behind the controversial eating disorder chatbot Tessa

focus

Mom launches Girl Scout troop for LGBTQ youth in Texas

Bispecific antibodies are next new thing in cancer immunotherapy

Food as medicine: Medically tailored meals may get standardized

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Altering the blood type of lungs raises potential for universal organs for transplants

The Readout: Lenmeldy, GLP

focus

hotspot

entertainment

hotspot